On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

Projektinformationen

DISRUPT

ID Finanzhilfevereinbarung: 101099663

DOI

10.3030/101099663

Projekt abgeschlossen

EK-Unterschriftsdatum 15 Dezember 2022

Startdatum 1 Dezember 2022

Enddatum 31 Mai 2026

Finanziert unter

• The European Innovation Council (EIC)

Gesamtkosten

€ 3 018 312,50

EU-Beitrag

€ 3 018 312,50

Koordiniert durch

UNIVERSITAT POLITECNICA DE VALENCIA
Spain

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Demonstrators, pilots, prototypes (2)

Demonstrator for infected cell distinction

Validation of the device for distinguishing viral from bacterial infections by RI maps of various blood cell types

Demonstrator for cancer detection

Validation of the device for cancer cells detection

Documents, reports (4)

Final version of Plan for Dissemination and Exploitation Including Communication Activities

Summary of the main achievements with KPI’s of the activities sketched in D5.6

Management and Quality Plan

Initial report with the management structure and quality indicators

Plan for Dissemination and Exploitation Including Communication Activities

Full plan of dissemination, communication and IPR within the project

Website and project logo

Website and project logo information with also social media links

Data Management Plan (3)

RP2 update of the Data Management Plan

Second update of the information provided in D5.5

Data Management Plan

The handling and storage of the data will be set out in D5.2

RP1 update of the Data Management Plan

First update of the information provided in D5.4

Veröffentlichungen

Peer reviewed articles (2)

The Impact of Tube Type, Centrifugation Conditions, and Hemolysis on Plasma Circulating MicroRNAs

Autoren: Belén Pastor-Navarro; Marta Ramírez-Calvo; Isabel Gil-Aldea; Isabel Cortell-Granero; José A. López-Guerrero
Veröffentlicht in: Diagnostics, 2024, ISSN 2075-4418
Herausgeber: MDPI
DOI: 10.3390/DIAGNOSTICS14212369

Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial

Autoren: Pellegrino B.; Capoluongo E. D.; Bagnoli M.; Arenare L.; Califano D.; Scambia G.; Cecere S. C.; Silini E. M.; Scaglione G. L.; Spina A.; Tognon G.; Campanini N.; Pisano C.; Russo D.; Pettinato A.; Scollo P.; Iemmolo R.; De Cecco L.; Musolino A.; Marchini S.; Beltrame L.; Paracchini L.; Perrone F.; Mezzanzanica D.; Pignata S.
Veröffentlicht in: ESMO Open, 2025, ISSN 2059-7029
Herausgeber: Elsevier
DOI: 10.1016/J.ESMOOP.2024.104091